Sung Joo Lee, Orum Therapeutics CEO
July 16, 2024 07:00 AM EDT
Startups
Deals
Cell/Gene Tx

Af­ter last year's Im­muno­Gen pact, Ver­tex finds an­oth­er con­di­tion­ing agent part­ner in Orum

Kyle LaHucik

Senior Reporter

Ver­tex is part­ner­ing with a US and South Ko­re­an biotech to see if it can of­fer pa­tients a bet­ter con­di­tion­ing agent to make way for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Lykos CEO Amy Emer­son re­signs

FDA rais­es an­timi­cro­bial re­sis­tance con­cerns ahead of ad­comm for Iterum's UTI treat­ment

No­var­tis pays $15M up­front to li­cense Voy­ager pro­gram; Boehringer ad­vances ge­o­graph­ic at­ro­phy drug

CBER chief fore­casts bet­ter glob­al reg­u­la­to­ry con­ver­gence around cell and gene ther­a­pies

Bio­Marin re­struc­tures fol­low­ing staff shake­up, slow Roc­ta­vian sales

sponsored

How to se­cure full en­roll­ment and a 30x ROI: A con­ver­sa­tion with the CEO of the bou­tique en­roll­ment agency do­ing just ...

A service from the Financial Times